Washington, DC Partner Liz Gray will be presenting, “Reacting to Scrutiny of Clinical Trial Disclosures by the SEC,” at the American Conference Institute’s 7th National Conference on Managing Legal Risks in Structuring & Conducting Clinical Trials in San Francisco on July 16.
Specifically, she will discuss:
- How FDA and SEC cooperation (Referral Process and Centralized Procedures) have affected scrutiny of clinical trial disclosures
- Complying with SEC reporting requirements pre- and post-approval
- Reconciling FDA/SEC disclaimer requirements
- Factoring in recent enforcement activities by the SEC and FDA
- Lessons learned from ImClone, TKT, ICN, and NY Executive Law 63(12)
- Disclosing clinical trial information that has been made available to the FDA but not publicly disclosed
- Determining what FDA actions to disclose and how to disclose them for accurate interpretation by the securities market
- Alleviating securities concerns: whether databank entries constitute “forward-looking statements” for investor reliance; and
- Controlling and monitoring material inside information and disclosing material facts to shareholders
Related Insights
31 December 2024
Foley Viewpoints
SEC Enforcement Action Against Church & Dwight Director: Lessons for Outside Directors
The SEC’s settlement with James R. Craigie, former CEO, chairman, and director of Church & Dwight Co. Inc., for violating proxy disclosure rules by standing for election as an independent director without disclosing his close personal friendship with a senior Church & Dwight executive has caused consternation in the legal community regarding when a friendship jeopardizes director independence under stock exchange rules.
31 December 2024
Manufacturing Industry Advisor
The State of the Law of Requirements Contracts
Amid increasing pressure on supply chains across the globe, multiple recent court opinions have disrupted the law of requirements contracts.
30 December 2024
Foley Viewpoints
Controlling Entities to Dealer Contracts Subject to Puerto Rico’s Law 75 May Be Liable for Tortious Interference
Plaintiffs asserting claims for tortious interference of contracts covered by Puerto Rico’s Dealer’s Contracts Act, commonly known as Law 75, may automatically satisfy one element of such a claim. Law 75 regulates relationships between distributors and manufacturers.